REFERENCES
1. Hageman IC, van Rooij IALM, de Blaauw I, Trajanovska M, King SK. A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis 2023;18:106.
2. Pogue RE, Cavalcanti DP, Shanker S, et al. Rare genetic diseases: update on diagnosis, treatment and online resources. Drug Discov Today 2018;23:187-95.
4. Fidan Ç, Örün H, Alper AB, et al. Expanded newborn bloodspot screening: developed country examples and what can be done in Turkey. Intractable Rare Dis Res 2022;11:63-9.
5. Bick D, Ahmed A, Deen D, et al. Newborn screening by genomic sequencing: opportunities and challenges. Int J Neonatal Screen 2022;8:40.
6. Ceyhan-Birsoy O, Machini K, Lebo MS, et al. A curated gene list for reporting results of newborn genomic sequencing. Genet Med 2017;19:809-18.
7. Kingsmore SF, Smith LD, Kunard CM, et al. A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. Am J Hum Genet 2022;109:1605-19.
8. Kingsmore SF; BeginNGS Consortium. Dispatches from biotech beginning BeginNGS: rapid newborn genome sequencing to end the diagnostic and therapeutic odyssey. Am J Med Genet C Semin Med Genet 2022;190:243-56.
9. Gaff CL, M Winship I, M Forrest S, et al. Preparing for genomic medicine: a real world demonstration of health system change. NPJ Genom Med 2017;2:16.
10. Holm IA, Agrawal PB, Ceyhan-Birsoy O, et al. BabySeq Project Team. The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr 2018;18:225.
11. Pichini A, Ahmed A, Patch C, et al. Developing a national newborn genomes program: an approach driven by ethics, engagement and co-design. Front Genet 2022;13:866168.
12. Alvarellos M, Sheppard HE, Knarston I, et al. Democratizing clinical-genomic data: how federated platforms can promote benefits sharing in genomics. Front Genet 2022;13:1045450.
13. Chaterji S, Koo J, Li N, Meyer F, Grama A, Bagchi S. Federation in genomics pipelines: techniques and challenges. Brief Bioinform 2019;20:235-44.
14. Rehm HL, Page AJH, Smith L, et al. GA4GH: international policies and standards for data sharing across genomic research and healthcare. Cell Genom 2021;1:100029.
15. Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. J Am Med Inform Assoc 2022;30:103-11.
16. Mayo KR, Basford MA, Carroll RJ, et al. The all of Us data and research center: creating a secure, scalable, and sustainable ecosystem for biomedical research. Annu Rev Biomed Data Sci 2023;6:443-64.
17. Nik-Zainal S, Seeger T, Fennessy R, et al. Multi-party trusted research environment federation: Establishing infrastructure for secure analysis across different clinical-genomic datasets. Zenodo ;2022:online ahead of print.
18. Rueda M, Ariosa R, Moldes M, Rambla J. Beacon v2 reference implementation: a toolkit to enable federated sharing of genomic and phenotypic data. Bioinformatics 2022;38:4656-7.
19. Hunter A, Lewis C, Hill M, et al. Public and patient involvement in research to support genome services development in the UK. J Transl Genet Genom 2023;7:17-26.
20. Goldenberg AJ, Lloyd-Puryear M, Brosco JP, et al. Bioethics and Legal Workgroup of the Newborn Screening Translational Research Network. Including ELSI research questions in newborn screening pilot studies. Genet Med 2019;21:525-33.
21. Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.
